Published in Mol Biochem Parasitol on April 25, 2001
Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents. Mol Cell (2004) 2.02
pfcrt polymorphism and chloroquine resistance in Plasmodium falciparum strains isolated in Cambodia. Antimicrob Agents Chemother (2003) 1.89
Chloroquine resistance before and after its withdrawal in Kenya. Malar J (2009) 1.88
Chloroquine-resistant haplotype Plasmodium falciparum parasites, Haiti. Emerg Infect Dis (2009) 1.54
Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa. Am J Trop Med Hyg (2010) 1.18
Molecular characterisation of drug-resistant Plasmodium falciparum from Thailand. Malar J (2002) 1.11
In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria. Acta Trop (2011) 0.97
Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal. Malar J (2011) 0.95
Microsatellite polymorphism within pfcrt provides evidence of continuing evolution of chloroquine-resistant alleles in Papua New Guinea. Malar J (2007) 0.94
Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations. Pediatr Res (2009) 0.94
Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011. Malar J (2013) 0.93
Role of Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes on in vitro chloroquine resistance in isolates of Plasmodium falciparum from Thailand. Am J Trop Med Hyg (2011) 0.91
Chloroquine Resistant Plasmodium falciparum in Nigeria: Relationship between pfcrt and pfmdr1 Polymorphisms, In-Vitro Resistance and Treatment Outcome. Open Trop Med J (2008) 0.88
Association between prevalence of chloroquine resistance and unusual mutation in pfmdr-I and pfcrt genes in India. Am J Trop Med Hyg (2013) 0.87
Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa. Malar J (2006) 0.86
Polymorphism in plasmodium falciparum drug transporter proteins and reversal of in vitro chloroquine resistance by a 9,10-dihydroethanoanthracene derivative. Antimicrob Agents Chemother (2004) 0.86
Quantitative genome re-sequencing defines multiple mutations conferring chloroquine resistance in rodent malaria. BMC Genomics (2012) 0.84
Antimalarial drug resistance: An overview. Trop Parasitol (2016) 0.82
No Polymorphism in Plasmodium falciparum K13 Propeller Gene in Clinical Isolates from Kolkata, India. J Pathog (2015) 0.82
Double mutation in the pfmdr1 gene is associated with emergence of chloroquine-resistant Plasmodium falciparum malaria in Eastern India. Antimicrob Agents Chemother (2014) 0.81
In vitro increase in chloroquine accumulation induced by dihydroethano- and ethenoanthracene derivatives in Plasmodium falciparum-parasitized erythrocytes. Antimicrob Agents Chemother (2002) 0.80
Rapid detection of a molecular marker for chloroquine-resistant falciparum malaria. Antimicrob Agents Chemother (2002) 0.80
Diversity of Plasmodium falciparum chloroquine resistance transporter (pfcrt) exon 2 haplotypes in the Pacific from 1959 to 1979. PLoS One (2012) 0.80
Genetics of chloroquine-resistant malaria: a haplotypic view. Mem Inst Oswaldo Cruz (2013) 0.78
The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia. Malar J (2016) 0.77
Surveillance of travellers: an additional tool for tracking antimalarial drug resistance in endemic countries. PLoS One (2013) 0.77
Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa. Mol Biochem Parasitol (1995) 2.29
Airway smooth muscle, tidal stretches, and dynamically determined contractile states. Am J Respir Crit Care Med (1997) 2.26
Health related quality of life in patients with spina bifida: a prospective assessment before and after lower urinary tract reconstruction. J Urol (2009) 2.20
Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol Biochem Parasitol (1995) 1.71
In vitro study of drug sensitivity of Plasmodium falciparum: evaluation of a new semi-micro test. Am J Trop Med Hyg (1983) 1.69
In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg (1993) 1.57
In vitro activities of furoquinoline and acridone alkaloids against Plasmodium falciparum. Antimicrob Agents Chemother (1994) 1.55
Desipramine or cyproheptadine for reversing chloroquine resistance? Lancet (1990) 1.52
Plasmodium falciparum and Plasmodium vivax: lactate dehydrogenase activity and its application for in vitro drug susceptibility assay. Exp Parasitol (1995) 1.51
Plasmodium falciparum: molecular characterization of multidrug-resistant Cambodian isolates. Exp Parasitol (1996) 1.48
Parasite virulence factors during falciparum malaria: rosetting, cytoadherence, and modulation of cytoadherence by cytokines. Infect Immun (1993) 1.48
Rapid, nonradioactive screening for mutations in exons 10, 11, and 16 of the RET protooncogene associated with inherited medullary thyroid carcinoma. Clin Chem (1997) 1.42
Efficacy of amodiaquine against chloroquine-resistant malaria in Cameroon. Lancet (1991) 1.41
[Plasmodium falciparum malaria: type R1 resistance to quinine in west Africa]. Presse Med (1998) 1.38
In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs. Antimicrob Agents Chemother (1999) 1.35
In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg (1994) 1.28
In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives. Ann Trop Med Parasitol (1994) 1.21
[Plasmodium falciparum: interpretation of the semi-microtest of in vitro chemosensitivity by H3-hypoxanthine incorporation]. Pathol Biol (Paris) (1984) 1.20
In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum. Br J Clin Pharmacol (1992) 1.19
Blood levels and in vitro activity of desethylchloroquine against Plasmodium falciparum. Lancet (1984) 1.16
Disposition of monodesethylamodiaquine after a single oral dose of amodiaquine and three regimens for prophylaxis against Plasmodium falciparum malaria. Eur J Clin Pharmacol (1987) 1.15
In vitro activity of halofantrine and its relationship to other standard antimalarial drugs against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg (1992) 1.13
Reversal of chloroquine resistance with desipramine in isolates of Plasmodium falciparum from Central and West Africa. Trans R Soc Trop Med Hyg (1991) 1.12
Severe chloroquine-resistant falciparum malaria in Gabon with decreased sensitivity to quinine. Trans R Soc Trop Med Hyg (1986) 1.07
Unreliability of Dill Glazko test in detecting chloroquine in urine. Lancet (1985) 1.06
Chloroquine-resistant falciparum malaria in Benin. Lancet (1986) 1.06
Use of molecular beacons to detect an antifolate resistance-associated mutation in Plasmodium falciparum. Antimicrob Agents Chemother (2000) 1.04
In vitro activity of monodesethylamodiaquine and amopyroquine against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg (1993) 1.02
Plasmodium falciparum: detection of P-glycoprotein in chloroquine-susceptible and chloroquine-resistant clones and isolates. Exp Parasitol (1995) 1.02
Chloroquine uptake by Plasmodium falciparum-infected human erythrocytes during in vitro culture and its relationship to chloroquine resistance. Antimicrob Agents Chemother (1985) 1.01
High Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine in Harper, Liberia: results in vivo and analysis of point mutations. Trans R Soc Trop Med Hyg (2003) 1.01
Plasmodium falciparum: detection of antifolate resistance by mutation-specific restriction enzyme digestion. Exp Parasitol (1995) 1.00
Chloroquine-potentiating action of antihistaminics in Plasmodium falciparum in vitro. Ann Trop Med Parasitol (1991) 1.00
Plasmodium falciparum in Madagascar: in vivo and in vitro sensitivity to seven drugs. Ann Trop Med Parasitol (1985) 0.97
Chloroquine-resistant falciparum malaria in Mauritania. Lancet (1995) 0.97
Levels of cytokines in plasma during Plasmodium falciparum malaria attacks. J Clin Microbiol (1991) 0.97
Treatment of imported cases of falciparum malaria in France with halofantrine. Trans R Soc Trop Med Hyg (1986) 0.97
Failure of anti-malarial prophylaxis with mefloquine in Africa. Trans R Soc Trop Med Hyg (1991) 0.96
Plasmodium falciparum: drug sensitivity in vitro of isolates before and after adaptation to continuous culture. Exp Parasitol (1983) 0.95
[In vitro activity of various antimalarials (chloroquine, amodiaquine, quinine and mefloquine) against 32 isolates of Plasmodium falciparum in French Guiana]. Bull Soc Pathol Exot Filiales (1988) 0.94
In vitro activities of chloroquine in combination with chlorpromazine or prochlorperazine against isolates of Plasmodium falciparum. Antimicrob Agents Chemother (1992) 0.93
In vitro activity of pyronaridine against African strains of Plasmodium falciparum. Ann Trop Med Parasitol (1992) 0.93
Molecular survey of Plasmodium falciparum resistance in south-eastern Iran. Ann Trop Med Parasitol (2003) 0.92
Short-term in vitro culture of Plasmodium vivax and P. ovale for drug-susceptibility testing. Parasitol Res (1994) 0.92
Clinical efficacy and pharmacokinetics of micronized halofantrine for the treatment of acute uncomplicated falciparum malaria in nonimmune patients. Am J Trop Med Hyg (1994) 0.91
Atovaquone plus proguanil versus halofantrine for the treatment of imported acute uncomplicated Plasmodium falciparum malaria in non-immune adults: a randomized comparative trial. Am J Trop Med Hyg (2001) 0.91
Iron chelators as antimalarial agents: in vitro activity of dicatecholate against Plasmodium falciparum. J Antimicrob Chemother (2002) 0.91
Susceptibility of Plasmodium falciparum strains to mefloquine in an urban area in Senegal. Bull World Health Organ (1992) 0.90
Association between antifol resistance in vitro and DHFR gene point mutation in Plasmodium falciparum isolates. Trans R Soc Trop Med Hyg (1996) 0.90
Dichlorquinazine (alpha 4-aminoquinoline) effective in vitro against chloroquine-resistant Plasmodium falciparum. Lancet (1983) 0.89
Sudden increase in number of isolates of Plasmodium falciparum resistant to chloroquine in Madagascar. Trans R Soc Trop Med Hyg (1990) 0.89
Cytoadherence characteristics to endothelial receptors ICAM-1 and CD36 of Plasmodium falciparum populations from severe and uncomplicated malaria cases. Parasite (2008) 0.89
Reversal of chloroquine resistance with cyproheptadine in 'wild' strains of Plasmodium falciparum. Trans R Soc Trop Med Hyg (1991) 0.89
Chloroquine-resistant Plasmodium falciparum malaria in Senegal. Trans R Soc Trop Med Hyg (1990) 0.89
[A fatal case of chloroquine-resistant neuromalaria in a traveller to Cameroon]. Bull Soc Pathol Exot Filiales (1986) 0.88
Efficacy of a loading dose of oral chloroquine in a 36-hour treatment schedule for uncomplicated plasmodium falciparum malaria. Antimicrob Agents Chemother (1991) 0.87
In vitro activity of bisquinoline WR268,668 against African clones and isolates of Plasmodium falciparum. Am J Trop Med Hyg (1994) 0.87
Reduced sensitivity of Plasmodium falciparum to mefloquine in West Africa. Lancet (1988) 0.87
Reduction of coma by quinine loading dose in falciparum cerebral malaria. Lancet (1991) 0.87
Evaluating the efficacy of chloroquine in febrile Guinean children infected with Plasmodium falciparum by a simplified in vivo test. Bull World Health Organ (1992) 0.87
Cloning and sequencing of Plasmodium falciparum DNA fragments containing repetitive regions potentially coding for histidine-rich proteins: identification of two overlapping reading frames. Biochem Biophys Res Commun (1987) 0.87
In vitro activities of novel catecholate siderophores against Plasmodium falciparum. Antimicrob Agents Chemother (1996) 0.87
In vitro and in vivo potentiation of chloroquine against malaria parasites by an enantiomer of amlodipine. Antimicrob Agents Chemother (1991) 0.87
Profile and evolution of the chemosusceptibility of falciparum malaria imported into France in 2000. Euro Surveill (2002) 0.87
Type RI resistance to halofantrine in West Africa. Trop Med Parasitol (1991) 0.87
Analysis of kappa and omega repeats of the cg2 gene and chloroquine susceptibility in isolates of Plasmodium falciparum from sub-Saharan Africa. Mol Biochem Parasitol (1999) 0.86
Predictive factors of severe disease secondary to falciparum malaria among travelers. Pathol Biol (Paris) (2010) 0.86
Plasma concentrations of the enantiomers of halofantrine and its main metabolite in malaria patients. Eur J Clin Pharmacol (1994) 0.86
In vitro reversal of chloroquine resistance with chlorpheniramine against African isolates of Plasmodium falciparum. Jpn J Med Sci Biol (1994) 0.85
Antimalarial activity in vitro of the N-desbutyl derivative of halofantrine. Trans R Soc Trop Med Hyg (1992) 0.85
[Geographic approach to the epidemiology of chloroquine-resistance of Plasmodium falciparum in tropical Africa]. Ann Soc Belg Med Trop (1991) 0.85
Evolution of chloroquine resistance in central and west Africa. Trop Med Parasitol (1993) 0.84
Activity in vitro of doxycycline against multidrug-resistant Plasmodium falciparum. Trans R Soc Trop Med Hyg (1993) 0.84
Pharmacokinetics of intramuscular amopyroquin in healthy subjects and determination of a therapeutic regimen for Plasmodium falciparum malaria. Antimicrob Agents Chemother (1989) 0.83
Susceptibility of Plasmodium falciparum to a peroxidase-mediated oxygen-dependent microbicidal system. Infect Immun (1988) 0.83
In vitro activity of atovaquone against the African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg (1995) 0.83
[Surveillance of Plasmodium falciparum drug sensitivity in Yaounde and its surroundings (Cameroon). In vivo and in vitro study]. Bull Soc Pathol Exot Filiales (1989) 0.83
Absence of antimalarial activity or interaction with mefloquine enantiomers in vitro of the main human metabolite of mefloquine. Trans R Soc Trop Med Hyg (1991) 0.82
Potentiation of chloroquine activity against Plasmodium falciparum by the peroxidase-hydrogen peroxide system. Antimicrob Agents Chemother (1990) 0.82
Antibodies to the PF155 antigen of Plasmodium falciparum: measurement by cell-ELISA and correlation with expected immune protection. Am J Trop Med Hyg (1987) 0.82
DHFR gene point mutation as a predictor of Plasmodium falciparum resistance to cycloguanil in malaria cases from Africa imported to France. Trans R Soc Trop Med Hyg (1997) 0.82
In vitro sensitivity of Plasmodium falciparum to anti-folinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains. Bull Soc Pathol Exot (1997) 0.82
[Stability of P. Falciparum resistance to chloroquine between 1987 and 1989 in Mounana, Gabon]. Bull World Health Organ (1992) 0.82
Molecular characterisation of airport malaria: four cases in France during summer 1999. Parasite (2002) 0.81
In vitro antimalarial activity and chloroquine potentiating action of two bisbenzylisoquinoline enantiomer alkaloids isolated from Strychnopsis thouarsii and Spirospermum penduliflorum. Planta Med (1992) 0.81
Blood samples and chloroquine assay. Lancet (1983) 0.81
Plasmodium falciparum: in vitro drug interaction between chloroquine and enantiomers of amlodipine. Exp Parasitol (1991) 0.81
Publications by the American Academy of Pediatrics Section on Urology: the quality of research design and statistical methodology. J Urol (2009) 0.80
Application of an in vitro semi-microtest to the study of drug sensitivity of 66 Plasmodium falciparum isolates from 15 countries. Trans R Soc Trop Med Hyg (1984) 0.80
Chloroquine-resistant falciparum malaria in the Congo. Lancet (1985) 0.80
Susceptibility of African isolates of Plasmodium falciparum to artemisinin (qinghaosu). Trop Med Parasitol (1992) 0.80
The interferon compartment of the immune response in human malaria: I. Interferon inducers in Plasmodium falciparum cultures. J Interferon Res (1985) 0.80
[4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. III. Studies in three regions of the interior]. Arch Inst Pasteur Madagascar (1984) 0.80
[Stimulation of the chemiluminescence of human polymorphonuclear leukocytes in various stages of the intraerythrocyte development of Plasmodium falciparum]. C R Seances Soc Biol Fil (1988) 0.80
[4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. I. Study in two regions of the west coast]. Arch Inst Pasteur Madagascar (1984) 0.79
Plasmodium falciparum: pfcrt and DHFR mutations are associated with failure of chloroquine plus proguanil prophylaxis in travelers. J Infect Dis (2001) 0.79
Geographic diversity of Plasmodium falciparum antibodies in Madagascar. Lancet (1985) 0.79